Eva Markert
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Rheumatology top 10%
- Bone Tumor Diagnosis and Treatments
- Rheumatoid Arthritis Research and Therapies
Papers in
-
- Rheumatoid Arthritis Research and Therapies 3
- Bone Tumor Diagnosis and Treatments 2
- Urologic and reproductive health conditions 1
-
- Lung Cancer Treatments and Mutations 2
- Sarcoma Diagnosis and Treatment 2
- Prostate Cancer Treatment and Research 2
- Co-authors
- Stefan Diem (2 shared papers)Lukas Flatz (2 shared papers)Omar Hasan Ali (2 shared papers)Wolfram Jochum (1 shared paper)Lars Einar French (1 shared paper)Daniel E. Speiser (1 shared paper)Katrin Kerl (1 shared paper)Martin Früh (1 shared paper)
- Journals
- OncoImmunology (1 paper)Lara D. Veeken (1 paper)International Journal of Hematology (1 paper)Urologic Oncology Seminars and Original Investigations (1 paper)The American Journal of Surgical Pathology (1 paper)
- Partner nations
- GermanySwitzerlandCanada
In The Last Decade
Eva Markert
15 papers receiving 366 citations
Peers
Comparison fields: 5 of 35
- Oncology 132
- Rheumatology 73
- Pulmonary and Respiratory Medicine 114
- Transplantation 6
- Cancer Research 21
Countries citing papers authored by Eva Markert
This map shows the geographic impact of Eva Markert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Markert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Markert more than expected).
Fields of papers citing papers by Eva Markert
This network shows the impact of papers produced by Eva Markert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Markert. The network helps show where Eva Markert may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Markert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 110 | |
| 2 | 2011 | 100 | |
| 3 | 2019 | 53 | |
| 4 | 1997 | 27 | |
| 5 | 1997 | 17 | |
| 6 | Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interaction. | 1996 | 15 |
| 7 | 2010 | 12 | |
| 8 | 2022 | 11 | |
| 9 | Enhanced proliferation and decreased apoptosis in lung lavage cells of sarcoidosis patients. | 2006 | 8 |
| 10 | 2020 | 7 | |
| 11 | 2006 | 5 | |
| 12 | 2009 | 5 | |
| 13 | 2008 | 2 | |
| 14 | 2009 | 2 | |
| 15 | 2023 | 1 | |
| 16 | 2008 | 0 | |
| 17 | 2023 | 0 | |
| 18 | 2025 | 0 |
About Eva Markert
Eva Markert is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine, Oncology, Hematology and Neurology, having authored 18 papers that have together received 375 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (3 papers), Lung Cancer Treatments and Mutations (2 papers), Bone Tumor Diagnosis and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Sarcoma Diagnosis and Treatment (2 papers), Prostate Cancer Treatment and Research (2 papers), Chronic Myeloid Leukemia Treatments (1 paper) and Urologic and reproductive health conditions (1 paper). The work is most often cited by research in Oncology (132 citations), Rheumatology (73 citations), Pulmonary and Respiratory Medicine (114 citations), Transplantation (6 citations) and Cancer Research (21 citations). Eva Markert has collaborated with scholars based in Germany, Switzerland and Canada. Frequent co-authors include Stefan Diem, Lukas Flatz, Omar Hasan Ali, Wolfram Jochum, Lars Einar French, Daniel E. Speiser, Katrin Kerl, Martin Früh, Sascha Ansén and Silvia Querings. Their work appears in journals such as OncoImmunology, Lara D. Veeken, International Journal of Hematology, Urologic Oncology Seminars and Original Investigations and The American Journal of Surgical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.